Media Home
UN Web TV
UN Audiovisual Library
UN PhotoWHO / EBOLA VACCINE
Download
There is no media available to download.
Share
STORY: WHO / EBOLA VACCINE
TRT: 01:59
SOURCE: UNMEER
RESTRICTIONS: NONE
LANGUAGE: ENGLISH / NATS
DATELINE: 10 MARCH 2015, CONAKRY, GUINEA / 17 APRIL 2015, JIU, SIERRA LEONE
FILE - UNMEER - 10 MARCH 2015, CONAKRY, GUINEA
1. Wide shot, medical worker wearing personal protective equipment (PPE) carries the vaccine
2. Close up, vaccine and syringe
3. Tilt down, medical worker and WHO’s Ana Maria Henao Restrepo handling the vaccine
4. Tilt up, medical worker wearing PPE
5. Close up, medical worker’s hands
6. Various shots, volunteer being vaccinated
7. SOUNDBITE (English) Ana Maria Henao Restrepo, Medical Officer Immunization, Vaccine and Biological Department World Health Organization (WHO):
“We are going to vaccinate all the frontline workers, the people involved in the Ebola response, and we are going to use those data from these people, these volunteers, to assess whether or not the vaccine is safe, and second, we are going to take blood samples to evaluate the immune response after vaccination.”
FILE - UNMEER - 17 APRIL 2015, JIU, SIERRA LEONE
8. Med shot, nurse taking vaccine from refrigerated container
9. Close up, vaccine and syringe in container
10. Close up, nurse opening vaccine
11. Close up, nurse drawing vaccine into syringe
12. Med shot, nurse cleaning patient’s arm
13. Close up, vaccine being injected into patients arm
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.
The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination. In comparison, there were 23 cases 10 days or more after vaccination among those who did not receive the vaccine.
The trial was led by the World Health Organization, together with Guinea’s Ministry of Health, Medecins sans Frontieres and the Norwegian Institute of Public Health, in collaboration with other international partners.
During vaccine trials in Conakry last year, WHO’s Ana Maria Henao Restrepo said “we are going to vaccinate all the frontline workers, the people involved in the Ebola response, and we are going to use those data from these people, these volunteers, to assess whether or not the vaccine is safe, and second, we are going to take blood samples to evaluate the immune response after vaccination.”
Since Ebola virus was first identified in 1976, sporadic outbreaks have been reported in Africa. But the 2013-2016 West African Ebola outbreak, which resulted in more than 11,300 deaths, highlighted the need for a vaccine.
